Rocatinlimab may be effective in the treatment of moderate-to-severe atopic dermatitis
1. At week 16, all rocatinlimab groups reported significant improvements in eczema severity. 2....
Jan 31, 2023
1. At week 16, all rocatinlimab groups reported significant improvements in eczema severity. 2....
Jan 31, 2023
1. Epstein-Barr viral load monitoring was associated with reduced post-liver transplant...
Jan 31, 2023
1. Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab use are associated...
Jan 29, 2023
1. Among individuals with a higher body mass index, baseline vitamin D serum metabolite levels...
Jan 27, 2023
1. Global cure was achieved in 59% of the rezafungin group compared to 61% of the caspofungin...
Jan 27, 2023
1. In a case-control study, a diagnostic prediction tool was able to identify cerebral palsy with...
Jan 27, 2023
1. Empagliflozin led to a lower risk of kidney disease progression in patients with chronic kidney...
Jan 27, 2023
1. Patients with chronic obstructive pulmonary disease (COPD) had lower survival rates and greater...
Jan 27, 2023
1. A dominant deep-intron GAA repeat expansion in the FGF14 gene was found among French Canadian...
Jan 27, 2023
1. In patients with untreated paroxysmal atrial fibrillation, catheter ablation was associated...
Jan 25, 2023
1. Significantly more patients in the bimekizumab group reached ACR50 at week 16 compared to the...
Jan 25, 2023
1. In a cohort of portpartum mothers with limited maternal health literacy, the teach-back...